The global Vaccine Contract Manufacturing Market is witnessing rapid expansion, driven by increasing demand for scalable and efficient vaccine production technologies. According to Polaris Market Research, the market was valued at USD 5.16 billion in 2024 and is projected to reach USD 13.16 billion by 2032, growing at a CAGR of 12.4%. A key technological driver behind this growth is cell...